When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTRA - Natera's Signatera test granted two FDA Breakthrough Device Designations
Natera Inc.
Natera (NTRA) has been granted two additional Breakthrough Device Designations from the FDA for its Singatera molecular residual disease test.The designations will support the development of Signatera through phase 3 trials as a companion diagnostic to two cancer therapies.Another prior designation was granted in 2019.Natera shares are up 0.6% to $100.99 in morning trading.